METHODS FOR THE GENETIC ENGINEERING OF MAMMALIAN CELLS USING SERIAL SUPPLY
Patent Information
- Application Number
- ARP20250100619
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-03-06
- Filing Date
- 2025-03-06
- Publication Date
- 2026-09-16
Claims
This description relates to methods for improving the efficiency of gene editing in mammalian cells by serially delivering the gene-editing machinery and an incubation period between delivery stages that can range from approximately 1 hour to approximately 60 hours. The broad compatibility of these improved methods is demonstrated with multiple independent lines of induced pluripotent stem cells (iPSCs).
1. A method for generating induced pluripotent stem cells (iPSCs) by genetic engineering comprising: a) supplying a first payload comprising DNA to an iPSC culture; b) incubating the iPSC culture in a medium containing the first payload for approximately 12-60 hours; c) supplying the iPSC culture with a second payload comprising: an RNA and a nuclease, or an RNA and a nucleotide sequence encoding a nuclease; thereby mediating single- or double-strand DNA breakage at a target locus; and d) further incubating the iPSC culture for approximately 12-60 hours, thereby producing iPSCs by genetic engineering.
23. A method for generating human induced pluripotent stem cells (hiPSCs) by genetic engineering, comprising: a) delivering a first load to a hiPSC culture, wherein the first load comprises a donor nucleotide sequence comprising a knock-in nucleotide sequence, and wherein the first load is delivered using nucleofection; b) incubating the hiPSC culture with the first load for approximately 18-30 hours; and c) delivering a second load to the hiPSC culture, wherein the second load comprises Cas12a (Cpf1), Cas9, or Cas13, or a homolog or functional variant thereof, and a guide sequence that is complementary to a target nucleotide sequence; thereby producing hiPSCs by genetic engineering.
28. A method for generating mammalian cells by genetic engineering comprising: a) supplying a first load comprising DNA to a mammalian cell culture; b) incubating the mammalian cell culture in a medium containing the first load for approximately 12-60 hours; and c) supplying the mammalian cell culture with a second load comprising an RNA, a nuclease, and / or a nucleotide sequence encoding a nuclease, thereby mediating single- or double-strand DNA breakage at a target locus; and d) further incubating the mammalian cell culture for approximately 12-60 hours, thereby producing mammalian cells by genetic engineering.